Brief: Dyne Therapeutics Receives Orphan Drug Designation In Japan For Dyne-251 In Duchenne Muscular Dystrophy

Dyne Therapeutics

29/09/2025 14:18

Sept 29 (Reuters) - Dyne Therapeutics Inc DYN.O:

DYNE THERAPEUTICS RECEIVES ORPHAN DRUG DESIGNATION IN JAPAN FOR DYNE-251 IN DUCHENNE MUSCULAR DYSTROPHY

Source text: ID:nGNX9kyCWL

Further company coverage: DYN.O

 ((Reuters.Briefs@thomsonreuters.com;))